David J Einstein

17PUBLICATIONS

134CO-AUTHORS

Predictive and prognostic markersMolecular targetsComparative religious studiesCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|May 11, 2026

Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.

|Nov 20, 2025

Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Oct 23, 2025

Preclinical Activity of the DLL3-Targeted T-cell Engager MK-6070 in Neuroendocrine Prostate Cancer.

Sheng-Yu Ku, Nishat Manzar, Maria Mica Garcia

|Oct 03, 2025

Preclinical Activity of the DLL3-Targeted T-cell Engager MK-6070 in Neuroendocrine Prostate Cancer.

Sheng-Yu Ku, Nishat Manzar, Maria Mica Garcia

|Aug 12, 2025

Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.

Jude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben

|Sep 06, 2024

Reply to B. Tombal et al.

David J Einstein, Meredith M Regan, Julia S Stevens

Pageof 3

Frequent Collaborators

11 joint publications

Steven P Balk

Joshua W Russo

Adam G Sowalsky

Huihui Ye

Mary-Ellen Taplin

David F McDermott

Meredith M Regan

Moshe Ornstein

Sabina Signoretti

Russell Z Szmulewitz

Frequent Collaborators

11 joint publications

Steven P Balk

3 joint publications

Joshua W Russo

3 joint publications

Adam G Sowalsky

3 joint publications

Huihui Ye